ISPOR Europe 2019
2-6 November 2019; Copenhagen, Denmark
Monday, 4 November
Assessing the quality and coherence of network meta-analyses of biologics in plaque psoriasis - what does all this evidence synthesis tell us?
Wright E, Yasmeen N, Malottki K, Sawyer L, Borg E, Schwenke C, Warren R
Network meta-analysis comparing palbociclib plus fulvestrant with everolimus plus exemestane for HR+/HER2- advanced breast cancer that has become resistant to previous endocrine therapy
LeReun C, Gentilini A, Large S, Chowdhury M, Smith TA, Rinciog C
Tuesday, 5 November
Determining the baseline strategy in a cost-effectiveness analysis with treatment sequences
Giulia Viola M, Diamantopoulos A, Sawyer L
Wednesday, 6 November
Colectomy for ulcerative colitis in the United Kingdom: A review of incidence and complications
Diamantopoulos A, Lohan C, Sawyer L
An economic evaluation of tofacitinib in the treatment of moderately to severely active ulcerative colitis in the United Kingdom
Diamantopoulos A, Lohan C, Le Reun C, Wright E, Bohm N, Sawyer L
A systematic review and network meta-analysis to evaluate the efficacy and safety of tofacitinib in the treatment of moderately to severely active ulcerative colitis
Le Reun C, Wright E, Lohan C, Diamantopoulos A, Bohm N, Sawyer L